Free Trial

Stevanato Group (STVN) Competitors

€19.57
+0.41 (+2.14%)
(As of 05/30/2024 09:04 PM ET)

STVN vs. ATNFW, SXTPW, ACONW, AIMDW, DRTSW, ALVOW, ALVO, AONCW, AONC, and APLMW

Should you be buying Stevanato Group stock or one of its competitors? The main competitors of Stevanato Group include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), Ainos (AIMDW), Alpha Tau Medical (DRTSW), Alvotech (ALVOW), Alvotech (ALVO), American Oncology Network (AONCW), American Oncology Network (AONC), and Apollomics (APLMW). These companies are all part of the "medical" sector.

Stevanato Group vs.

Stevanato Group (NYSE:STVN) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, earnings, profitability, analyst recommendations, dividends, valuation, risk and community ranking.

In the previous week, Stevanato Group had 6 more articles in the media than 180 Life Sciences. MarketBeat recorded 8 mentions for Stevanato Group and 2 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 1.87 beat Stevanato Group's score of 0.22 indicating that 180 Life Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
Stevanato Group Neutral
180 Life Sciences Very Positive

Stevanato Group has higher revenue and earnings than 180 Life Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Stevanato Group$1.17BN/A$157.62M$0.5535.58
180 Life SciencesN/AN/AN/AN/AN/A

Stevanato Group has a net margin of 12.57% compared to 180 Life Sciences' net margin of 0.00%. Stevanato Group's return on equity of 12.61% beat 180 Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Stevanato Group12.57% 12.61% 7.25%
180 Life Sciences N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stevanato Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71
180 Life Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Stevanato Group received 26 more outperform votes than 180 Life Sciences when rated by MarketBeat users.

CompanyUnderperformOutperform
Stevanato GroupOutperform Votes
26
63.41%
Underperform Votes
15
36.59%
180 Life SciencesN/AN/A

Summary

Stevanato Group beats 180 Life Sciences on 7 of the 8 factors compared between the two stocks.

Get Stevanato Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for STVN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding STVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

STVN vs. The Competition

MetricStevanato GroupSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market CapN/A$3.83B$5.04B$17.55B
Dividend YieldN/A1.79%2.84%3.53%
P/E Ratio35.5816.00165.9825.81
Price / SalesN/A73.942,437.8910.43
Price / Cash22.8447.9135.0619.29
Price / Book4.725.035.585.86
Net Income$157.62M$4.50M$105.68M$976.92M
7 Day Performance-2.88%1.10%0.89%0.92%
1 Month Performance-30.21%1.19%3.03%4.70%
1 Year Performance-26.40%17.90%6.15%23.18%

Stevanato Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATNFW
180 Life Sciences
0 of 5 stars
$0.01
flat
N/A-44.0%$0.00N/A0.004Gap Up
High Trading Volume
SXTPW
60 Degrees Pharmaceuticals
0 of 5 stars
$0.10
flat
N/AN/A$0.00$253,573.000.002Gap Up
ACONW
Aclarion
0 of 5 stars
$0.03
flat
N/A-74.9%$0.00$75,404.000.004Gap Down
AIMDW
Ainos
0 of 5 stars
$0.07
flat
N/A-80.6%$0.00$93,677.000.0046Positive News
DRTSW
Alpha Tau Medical
0 of 5 stars
$0.22
flat
N/A-28.1%$0.00N/A0.00121Short Interest ↑
News Coverage
Positive News
Gap Down
ALVOW
Alvotech
0 of 5 stars
$3.10
flat
N/A+243.0%$0.00$91.43M0.00999
ALVO
Alvotech
0 of 5 stars
$13.94
+3.3%
$12.67
-9.1%
N/A$0.00$93.38M-5.741,026
AONCW
American Oncology Network
0 of 5 stars
$0.09
-58.2%
N/AN/A$0.00$1.34B0.001,525Gap Down
AONC
American Oncology Network
0 of 5 stars
$1.70
-35.4%
N/AN/A$0.00$1.34B0.001,525Gap Down
High Trading Volume
APLMW
Apollomics
0 of 5 stars
$0.01
flat
N/A-61.3%$0.00N/A0.0059Positive News
Gap Up

Related Companies and Tools

This page (NYSE:STVN) was last updated on 5/31/2024 by MarketBeat.com Staff

From Our Partners